Working to minimise the risk of bleeding in dental surgery
Many patients may have compromised haemostasis, either due to haemophilia or from receiving anticoagulant therapy. As a result of the reduced clotting ability in these patients, any dental surgical intervention carries the potential for adverse events.
The use of anticoagulants or antithrombotic agents is becoming more widespread and so this problem is becoming more common. The challenge is trying to find a balance between avoiding the cardiovascular issues and avoiding serious bleeds.
ParaPharm Development Ltd. is working closely with dental practitioners in this area. In this way PPDV strives to improve the lives of patients with compromised haemostasis.